The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

98 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
20
An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.EBI
University of Kwazulu-Natal
5
MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors.EBI
Takeda Pharmaceutical
39
Ion channels as therapeutic targets: a drug discovery perspective.EBI
Pfizer
3
Allyl m-trifluoromethyldiazirine mephobarbital: an unusually potent enantioselective and photoreactive barbiturate general anesthetic.EBI
Massachusetts General Hospital
44
Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the alpha5 subunit.EBI
Moltech
1
Synthesis of fluorine substituted pyrazolopyrimidines as potential leads for the development of PET-imaging agents for the GABAA receptors.EBI
Abx Advanced Biochemical Compounds
47
2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.EBI
University of Urbino
3
Condensation of muscimol or thiomuscimol with aminopyridazines yields GABA-A antagonists.EBI
Centre De Neurochimie Du Cnrs
15
Exploring subtype selectivity and metabolic stability of a novel series of ligands for the benzodiazepine binding site of the GABAA receptor.EBI
Novartis Institutes For Biomedical Research
3
Azaflavones compared to flavones as ligands to the benzodiazepine binding site of brain GABA(A) receptors.EBI
Lund University
2
 
A conformational study of ligands for omega modulatory sites of GABAa receptors by NOESY NMR spectroscopy and distance geometryEBI
TBA
16
Identification of anxiolytic/nonsedative agents among indol-3-ylglyoxylamides acting as functionally selective agonists at the gamma-aminobutyric acid-A (GABAA) alpha2 benzodiazepine receptor.EBI
Universita Di Pisa
7
Synthesis of GABAA receptor agonists and evaluation of their alpha-subunit selectivity and orientation in the GABA binding site.EBI
Johannes Gutenberg University
3
Proximity-accelerated chemical coupling reaction in the benzodiazepine-binding site of gamma-aminobutyric acid type A receptors: superposition of different allosteric modulators.EBI
University of Bern
2
Identification of anesthetic binding sites on human serum albumin using a novel etomidate photolabel.EBI
Imperial College
21
A Molecular Toolbox of Positron Emission Tomography Tracers for General Anesthesia Mechanism Research.EBI
Xiamen University
17
Insights into the medicinal chemistry of heterocycles integrated with a pyrazolo[1,5-EBI
Prince Sattam Bin Abdulaziz University
38
Novel imidazo[1,5-a]quinoxaline derivatives: SAR, selectivity and modeling challenges en route to the identification of an α5-GABAA receptor NAM.EBI
Gedeon Richter
173
β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer's Disease Therapy.EBI
Univ. Grenoble Alpes
3
Pharmacological Analysis of the Anti-inflammatory and Antiallodynic Effects of Zinagrandinolide E from EBI
Universidad Nacional Aut£Noma De M£Xico
32
Synthesis and biological evaluation of 7,8,9,10-tetrahydroimidazo[1,2-c]pyrido[3,4-e]pyrimdin-5(6H)-ones as functionally selective ligands of the benzodiazepine receptor site on the GABA(A) receptor.EBI
Neurogen
56
Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases.EBI
Palack£
32
Subtype Selective γ-Aminobutyric Acid Type A Receptor (GABAEBI
University of Sussex
18
Progress in the discovery of small molecule modulators of the Cys-loop superfamily receptors.EBI
Amgen
21
An overview of benzo[b]thiophene-based medicinal chemistry.EBI
Jain University
1
DEUTERATED COMPOUNDSBDB
Neurocrine Biosciences
27
KISSPEPTIN RECEPTOR (KISS1R) TARGETED THERAPEUTICS AND USES THEREOFBDB
Radionetics Oncology
61
COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONSBDB
TheRas
320
METHODS FOR TREATMENT OF CANCERBDB
Frontier Medicines
31
SUBSTITUTED TRIAZOLOHETEROARYL COMPOUNDS AS USP1 INHIBITORS AND THE USE THEREOFBDB
Impact Therapeutics (Shanghai)
128
SPIROCYCLIC MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATIONBDB
Genentech
97
Substituted benzamides as RIPK2 inhibitors for treatment of inflammatory bowel diseaseBDB
Boehringer Ingelheim International
26
THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDSBDB
Terns Pharmaceuticals
43
N2,N4-diphenylpyrimidine-2,4-diamine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancerBDB
Korea Research Institute of Chemical Technology
51
Substituted-3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeuticsBDB
Stingray Therapeutics
7
Substituted cyanopyrrolidines with activity as DUB inhibitorsBDB
Mission Therapeutics
52
Heterocyclic inhibitors of monocarboxylate transporterBDB
The Scripps Research Institute
135
Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived PRMT5-inhibitorsBDB
Ctxt
80
Pyridine derivativesBDB
Astellas Pharma
13
Preparation and use of 7a-heterocycle substituted-6,6-difluoro bicyclic himbacine derivatives as PAR-1 receptor antagonistsBDB
Merck Sharp & Dohme
46
N-benzoate group substituted benzopyrroline-2-one derivative and use thereofBDB
Beijing Hanmi Pharmaceutical
129
Cyclopropylamines as LSD1 inhibitorsBDB
Incyte
18
Methods of use of cyclopamine analogsBDB
Infinity Pharmaceuticals
167
Oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitorsBDB
Boehringer Ingelheim International
170
Compounds and compositions for inhibiting the activity of SHP2BDB
Novartis
60
Tricyclic heterocyclic compounds useful as inhibitors of TNFBDB
Bristol Myers Squibb
80
Aromatic heterocyclic compoundBDB
Mitsubishi Tanabe Pharma
63
Heteroaromatic compounds as BTK inhibitorsBDB
Boehringer Ingelheim International
31
2-pyridyloxy-3-ester-4-ether orexin receptor antagonistsBDB
Merck Sharp & Dohme
44
Factor XIa inhibitorsBDB
Merck Sharp & Dohme
130
Urea and amide derivatives of aminoalkylpiperazines and use thereofBDB
Southern Research Institute
6
N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disordersBDB
Ogeda
147
8-(piperazin-1-yl)-1,2,3,4-tetrahydro-isoquinoline derivativesBDB
Idorsia Pharmaceuticals
63
Styryl quinazoline derivatives as pharmaceutically active agentsBDB
Vichem Chemie Kutató
43
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitorsBDB
Oryzon Genomics
57
1, 3, 4-thiadiazole compounds and their use in treating cancerBDB
AstraZeneca
2
Compounds as rearranged during transfection (RET) inhibitorsBDB
Glaxosmithkline
14
Benzimidazole derivatives as RLK and ITK inhibitorsBDB
Principia Biopharma
166
Compounds, compositions, and methodsBDB
Denali Therapeutics
66
Pyridazinone compounds and their use as DAAO inhibitorsBDB
Takeda Pharmaceutical
36
Identification of stabilizers of multimeric proteinsBDB
The Leland Stanford Junior University
37
Bicyclic heterocycles as FGFR4 inhibitorsBDB
Incyte
352
Heterocyclylamines as PI3K inhibitorsBDB
Incyte Holdings
10
Chymase inhibitorsBDB
Boehringer Ingelheim International
8
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesBDB
Merck Sharpe & Dohme
14
Method of treating COVID-19BDB
Pfizer
15
Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.BDB
The Scripps Research Institute
2
Identification of RIP1 kinase as a specific cellular target of necrostatins.BDB
Tufts University
6
Splicing factor SF3b as a target of the antitumor natural product pladienolide.BDB
Eisai
33
Correlating solution binding and ESI-MS stabilities by incorporating solvation effects in a confined cucurbit[8]uril system.BDB
University of Cambridge
92
 
Chiral Recognition Thermodynamics of β-Cyclodextrin: The Thermodynamic Origin of Enantioselectivity and the Enthalpy-Entropy Compensation EffectBDB
Japan Science and Technology Agency
19
Discovery of a series of acrylic acids and their derivatives as chemical leads for selective EP3 receptor antagonists.BDB
Ono Pharmaceutical
70
Antagonists of the human A(2A) receptor. Part 6: Further optimization of pyrimidine-4-carboxamides.BDB
Vernalis (R&D)
17
Design, synthesis, and X-ray crystal structures of 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors.BDB
Duquesne University
84
Discovery and structure-activity relationship analysis of Staphylococcus aureus sortase A inhibitors.BDB
University of California Los Angeles
21
Identification of 2-aminobenzimidazoles as potent melanin-concentrating hormone 1-receptor (MCH1R) antagonists.BDB
Banyu Pharmaceutical
24
Second generation of BACE-1 inhibitors part 3: Towards non hydroxyethylamine transition state mimetics.BDB
Gsk
14
N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientation.BDB
Bristol Myers Squibb
37
Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.BDB
Kochi Medical School
59
Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins.BDB
Sapienza University of Rome
20
Chalcones: a valid scaffold for monoamine oxidases inhibitors.BDB
Sapienza University of Rome
17
Structure-based design, synthesis, and characterization of inhibitors of human and Plasmodium falciparum dihydroorotate dehydrogenases.BDB
University of Leeds
24
Synthesis of small molecule inhibitors of the orphan nuclear receptor steroidogenic factor-1 (NR5A1) based on isoquinolinone scaffolds.BDB
Scripps Florida
54
Synthesis and SAR of tolylamine 5-HT6 antagonists.BDB
Pfizer
48
Cdc7 kinase inhibitors: pyrrolopyridinones as potential antitumor agents. 1. Synthesis and structure-activity relationships.BDB
Nerviano Medical Sciences
12
Synthesis and SAR of potent LXR agonists containing an indole pharmacophore.BDB
Gsk
35
Pharmacophore guided discovery of small-molecule human apurinic/apyrimidinic endonuclease 1 inhibitors.BDB
University of Southern California
7
The molecular interactions of buspirone analogues with the serotonin transporter.BDB
National Medicines Institute
25
Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors.BDB
Sunesis Pharmaceuticals
30
Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines.BDB
AstraZeneca
21
Pharmacological and functional comparison of the polo-like kinase family: insight into inhibitor and substrate specificity.BDB
Abbott Laboratories